Comparative investigation of 11 Achillea collina Becker accessions concerning phenological, morphological, productional features and active agent content by Kindlovits, Sára et al.
6th International Symposium Breeding Research on Medicinal and Aromatic Plants, BREEDMAP 6, Quedlinburg, Germany, June 19-23, 2016 
 
76  Julius-Kühn-Archiv, 453, 2016 
FSL 1: Comparative investigation of 11 Achillea collina Becker accessions 
concerning phenological, morphological, productional features and active 
agent content 
Sára Kindlovits, Beatrix Cserháti, Katalin Inotai, Péter Rajhárt, Éva Németh-
Zámbori 
Szent István University, Faculty of Horticultural Sciences, Department of Medicinal and Aromatic Plants, Villányi 
str. 29-43. 1118 Budapest, Hungary, e-mail: Kindlovits.Sara@kertk.szie.hu (corresponding author) 
DOI 10.5073/jka.2016.453.025  
Abstract 
Eleven Achillea collina Becker accessions of different origin were tested in open field plots during 
three years for their phenological, morphological, productional features and active material con-
tent in Budapest, Hungary. Among the tested plant materials European selected cultivars, Hungar-
ian cultivated stocks and populations from wild growing habitats were investigated. 
Concerning flowering time, two types (early and late) were distinguished. Flowering time of the 
less abundant late type, represented by Hungarian variety ‘Azulenka’ and ‘Gb22’, started approxi-
mately 2 weeks later than that of the early flowering type. Plant height and length of flowering 
horizon varied only slightly among taxa, and increased after the first year of cultivation. The pro-
portion of useful plant organs in the drug was stable. Biomass and drug production of the investi-
gated genotypes was variable, late flowering types providing higher yields. Essential oil, 
proazulene, total phenolic and flavonoid content varied on a large scale among accessions and 
years. 
Results demonstrate the high intraspecific variability of A. collina and also the role of valuable 
genotypes in drug production. Selected cultivars may provide stable and good yields and drug 
quality under particular environmental conditions, while genotypes of wild origin may be valuable 
sources of future breeding programs. 
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Introduction 
Yarrow (Achillea) species are widely known and popular medicinal plants all over the world. The 
most important active agent of the drug (Millefolii herba) is the essential oil with proazulenes, but 
further compounds are also present, like flavonoids, phenolics and non volatile sesquiterpenes. 
Numerous therapeutic effects of yarrow have been demonstrated, among others spasmolytic, 
analgesic, anti-inflammatory and digestive activities (NÉMETH and BERNÁTH, 2008). Although the 
drug is officially listed in Ph. Eur., the drug quality seems to be often inadequate (BENEDEK et al., 
2008). This can be traced back to the high chemical diversity of the collected natural populations 
and sometimes even the cultivated ones. Therefore in the present study, 11 different A. collina taxa 
were tested including registered cultivars, wild originating populations and cultivated stocks to 
gather more information about the morphological and productional features and the drug quality 
of yarrow. 
Materials and Methods 
The comparative investigation of the 11 accessions (Table 1) was carried out in open field for three 
years, from 2012 to 2014. The experiment was installed in perennial stands in small plots in 3 repli-
cations. Phenological and morphological characteristics of the populations were compared, plant 
height and length of flowering horizon (flowers of appr. 20-30 cm stems) in 6 replications, the 
proportion of useful plant organs in the drug and the drug yield were measured (3 replications). 
The essential oil content was detected by the method described in PH.HG.VII (Achilleae herba) and 
the proazulene content of the oil by the method recommended in PH. HG. VIII. (Millefolii herba), 
both in 3 replications. The total phenolic content was determined in 3 replications by the method 
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of SINGLETON and ROSSI (1967), while determination of total flavonoid content was carried out by the 
method recommended in PH. HG. VIII. (Crataegi folium cum flore) in 3 replications. Samples were 
taken in each year, but in 2014 only essential oil and proazulene content were measured. The trial 
was carried out at the experimental field and in the laboratory of the department. 
Tab1 Origin and flowering time of the examined A. collina taxa. 
Taxa name Taxa code Origin Flowering time 
'Azulenka' T1 Hungarian variety late 
'Alba' T2 Slovakian variety early 
'Proa' T3 German variety early 
'Spak' T4 Swiss variety early 
'Földes' T5 cultivated stock from Földes, Hungary early 
'Gyula' T6 cultivated stock from Gyula, Hungary early 
'Kál' T7 cultivated stock from Kál, Hungary early 
'Gb9' T8 wild originating population from Aszód, Hungary late 
'Gb10' T9 wild originating population from Remeteszőlős, Hungary early 
'Gb22' T10 wild originating population from Nagymaros, Hungary early 
'Gb47' T11 Wild originating poulation from Mikóújfalu, Romania early 
Results 
A fortnightly shift in flowering time was observed between the earlier and later ('Azulenka’ and 
'Gb22‘) genotypes (Table 1.). Morphological, productional features and active agent content of the 
taxa are presented in Table 2. The plant height was relatively stable among the taxa, only ′Gb47‘ 
reached higher values (67.5 cm in 2013) than others. Otherwise height was found to be higher 
from the 2nd year, when plants reached their full development. Flowering horizon of the plants 
varied on a larger extent (between 15.8 and 31.9 in 2013) among accessions and similarly to plant 
height, increased slightly after the first year by 6 cm in the average. The proportion of useful plant 
organs (flowers and leaves) in the drug was found to be stable (60.4-67.8 %) among years and 
accessions. Highest drug yields were measured in genotype 'Azulenka‘ both in 2012 and in 2013 
(2.02 and 3.91 kg/10m2, respectively). The yields increased after the 1st year of cultivation by 36-
120 %, the production remained stable only in case of genotypes 'Alba‘ and 'Gb47‘. 
The essential oil content of the flowering horizon varied between 0.140 and 0.407 ml/100 g in d.w. 
In 2012 and 2013 the best results were achieved in accessions of wild origin: ‘Gb 47’ (0.395 and 
0.290 ml/100 g), while in 2014 the highest content was measured in population ‘Gyula’ (0.407 
ml/100 g). The proazulene content exceeded the requirements (0.02 % EO) of European Pharma-
copoeia VII. in each population and showed maximum values in ‘Gb22’ (0,174  and 0.122 %) in 
2012- 2013, and in ‘Gyula’ (0.150 %) in 2014 . 
The phenolic content of the studied populations varied from 139 to 220 mg GAE/100 g. In 2012 
highest value was determined in ‘Proa’ (220 mg GAE/100 g), while in 2013 ‘Gb22’ (185 mg GAE/100 
g) was found to be outstanding. Total flavonoid content of the taxa showed big differences, the 
values varied from 0.46 to 2.34 %, with highest concentrations in genotypes of wild origin: ‘Gb 22’ 
(2.06 %) and ‘Gb47’ (2.39 %). Both phenolic and flavonoid contents were unstable and their con-
tent changed inconsistently during the examined years.  
Our research was supported by TÁMOP 4.2.1./B-09/01/KMR/2010-0005 and TÁMOP 4.2.2./B-10.1-
2010-0023 programs. 
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Tab2 Characteristics of the examined genotypes (average values and standard deviation of experimental years) 
Taxa 
Plant 
height 
(cm) 
Length of 
flowering 
horizon 
(cm) 
Drug 
yield 
(kg/10 
m2) 
Essential 
oil con-
tent 
(mg/ 100 
g) 
Proazulene 
content 
(%) 
Total 
phenolic 
content 
(mg 
GAE/100 
g) 
Total 
flavonoid 
content 
(%) 
T1 
47.3 +/-4.9 15.3+/- 0.9 
2.97 +/-
1.33 
0.277 +/-
0.029 
0.099 +/-
0.016 
181.5 +/-
36.1 
1.57 +/-
0.19 
T2 
50.1 +/-5.8 19.3 +/-3.2 
1.96 +/-
0.02 
0.232 +/-
0.041 
0.077 +/-
0.012 
158.5 +/-
9.2 
1.69 +/-
0.54 
T3 
48.4 +/-9.0 18.7 +/-3.0 
1.70 +/-
0.55 
0.219 +/-
0.047 
0.114 +/-
0.018 
188.0 +/-
45.3 
1.78 +/-
0.61 
T4 
47.8 +/-11.2 18.6 +/-8.1 
1.44 +/-
0.57 
0.195 +/-
0.057 
0.097 +/-
0.032 
167.5 +/-
12.0 
1.97 +/-
0.36 
T5 
48.6+/-8.4 23.1 +/-1.7 
2.06 +/-
1.02 
0.277 +/-
0.030 
0.089 +/-
0.035 
174.5 +/-
16.3 
1.95 +/-
0.15 
T6 
45.5 +/-5.8 24.5 +/-7.1 
2.14 +/-
0.98 
0.302 +/-
0.092 
0.102 +/-
0.043 
154.0 +/-
11.3 
0.98 +/-
0.74 
T7 
46.1 +/-5.8 19.0 +/-2.3 
1.92 +/-
0.41 
0.202 +/-
0.050 0.056 +/-0.30 
171.0 +/-
43.8 
1.44 +/-
0.44 
T8 
46.7 +/-5.2 20.7 +/-1.1 
1.95 +/-
0.42 
0.177 +/-
0.033 
0.065 +/-
0.020 
149.0 +/-
14.1 
1.63 +/-
0.58 
T9 
47.4 +/-5.9 19.6 +/-4.1 
2.09 +/-
0.86 
0.203 +/-
0.013 
0.082 +/-
0.016 
175.5 +/-
29.0 
0.91 +/-
0.42 
T10 
47.7 +/-4.3 14.3 +/-2.1 
2.58 +/-
1.36 
0.287 +/-
0.051 
0.148 +/-
0.026 
173.0 +/-
17.0 
2.02 +/-
0.06 
T11 
56.8 +/-15.2 
23.2 +/-
11.7 
1.67 +/-
0.09 
0.354 +/-
0.056 
0.113 +/-
0.026 
147.0 +/-
29.7 
2.11 +/-
0.40 
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